Skip to main content

Week In Review: BeiGene Options DualityBio ADC In $1.3 Billion Agreement

Deals and financings, trials and approvals in the Chinese biotech/biopharma sphere.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.